First-trimester maternal serum C-reactive protein as a predictor of third-trimester impaired glucose tolerance.

Published

Journal Article

OBJECTIVE: We evaluated whether first-trimester high-sensitivity C-reactive protein (hsCRP), a suggested marker of pregnancy-associated hyperglycemia, predicts third-trimester impaired glucose tolerance (IGT) in a secondary analysis of a prospective cohort of nondiabetic singletons enrolled at <26 weeks gestation. STUDY DESIGN: We measured the association between hsCRP collected at <14 weeks among women classified as IGT (gestational diabetes screening results, 135 to <200 mg/dL) and those among normoglycemic women. Multivariable modeling estimated the association between log hsCRP and IGT, adjusted for maternal body mass index (BMI). RESULTS: Among 300 women, 13% (39 of 300) had IGT. The hsCRP was positively associated with glucose (P = .005). Compared with normoglycemic women, women with IGT had higher log hsCRP (0.87 ± 0.66 vs 0.67 ± 0.60, P = .04), but the association was not significant in adjusted models (adjusted odds ratio 1.20, 95% confidence interval 0.65-2.21). The hsCRP did not predict third-trimester IGT in this analysis when BMI is considered. CONCLUSION: Early identification of women at risk of IGT remains a priority, but the contribution of maternal BMI appears greater than hsCRP.

Full Text

Duke Authors

Cited Authors

  • Berggren, EK; Roeder, HA; Boggess, KA; Moss, K; Offenbacher, S; Campbell, E; Grotegut, CA

Published Date

  • January 2015

Published In

Volume / Issue

  • 22 / 1

Start / End Page

  • 90 - 93

PubMed ID

  • 24784714

Pubmed Central ID

  • 24784714

Electronic International Standard Serial Number (EISSN)

  • 1933-7205

Digital Object Identifier (DOI)

  • 10.1177/1933719114532843

Language

  • eng

Conference Location

  • United States